#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dedifferentiated liposarcoma Neurodegenerative disorder Cystic fibrosis lung Thrombocytosis Hyperoxaluria Myeloid leukaemia Cutaneous T-cell lymphoma Gastrointestinal stromal tumour Peripheral primitive neuroectodermal tumour of soft tissue Alveolar proteinosis Polyneuropathy Chordoma Glomerulonephritis membranous Thalassaemia beta Hepatic angiosarcoma More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory Wiskott-Aldrich syndrome – Trials in Disease Myelodysplastic syndrome with excess blasts Gaucher’s disease type III – Trials in Disease Splenic marginal zone lymphoma Basal cell naevus syndrome – Life with Disease Haemophilia B without inhibitors – Trials in Disease Epidermolysis bullosa Glomerulonephritis membranous – Treatment Mantle cell lymphoma refractory – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lolium Perenne Metamizole Lebrikizumab Aavanc80-5'Hotof Sufentanil Citrate Fosamprenavir Calcium Cx-044933 Stiripentol ARGININE GLUTAMATE Mrna-4157 Remestemcel Ibutamoren Mesilate Amiloride Neostigmine Methylsulfate Thiopental Sodium 2-DEOXY-D-GLUCOSE Quinine Dihydrochloride Crizotinib HTL0022537 Riluzole More therapies…

    Learn about Your Condition

    Renal cancer metastatic Retinoblastoma Cardiac amyloidosis Intestinal obstruction Liver transplant Lymphocytic lymphoma Strongyloidiasis Cerebellar ataxia CADASIL Pterygium Aplastic anaemia Inclusion body myositis Familial hypertriglyceridaemia BRAF gene mutation Renal impairment More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Study on Amiodarone Hydrochloride for Treating Atrial Fibrillation in Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Amiodarone Hydrochloride
    Denmark

  • Study on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Lactose Monohydrate
    • Apixaban
    • Rivaroxaban
    Finland Sweden

  • Study Comparing Two Amiodarone Doses to Maintain Heart Rhythm in Patients with Persistent Atrial Fibrillation After Cardioversion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Amiodarone Hydrochloride
    Spain

  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    • Diabetes mellitus
    Investigated Drugs:
    • Allopurinol
    Poland

  • Study on Preventing Blood Clots in Patients with New-Onset Post-Operative Atrial Fibrillation after CABG Using Apixaban and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clopidogrel Hydrogen Sulfate
    • Dabigatran Etexilate
    • Phenprocoumon
    Germany

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial flutter
    • Chronic coronary syndrome
    • Acute coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    • Acetylsalicylic Acid
    Belgium France Germany Italy The Netherlands Poland +1
Previous Page
1 2 3 4 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!